FDA Awards Priority Review Voucher to Sponsor of Rare Pediatric Disease Product EPIDIOLEX

Summary

The FDA has issued a priority review voucher to GW Research Ltd., the manufacturer of EPIDIOLEX, a rare pediatric disease product, following a review of its application under the FD&C Act and FDASIA.